Arif Nadaf

644 total citations · 2 hit papers
13 papers, 394 citations indexed

About

Arif Nadaf is a scholar working on Biomaterials, Biomedical Engineering and Molecular Biology. According to data from OpenAlex, Arif Nadaf has authored 13 papers receiving a total of 394 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Biomaterials, 6 papers in Biomedical Engineering and 3 papers in Molecular Biology. Recurrent topics in Arif Nadaf's work include Nanoparticle-Based Drug Delivery (5 papers), Nanoplatforms for cancer theranostics (3 papers) and Chronic Myeloid Leukemia Treatments (2 papers). Arif Nadaf is often cited by papers focused on Nanoparticle-Based Drug Delivery (5 papers), Nanoplatforms for cancer theranostics (3 papers) and Chronic Myeloid Leukemia Treatments (2 papers). Arif Nadaf collaborates with scholars based in India, Australia and Saudi Arabia. Arif Nadaf's co-authors include Nazeer Hasan, Prashant Kesharwani, Farhan Jalees Ahmad, Akash Kumar Gupta, Mohammad Imran, Yousuf Mohammed, Waleed Hassan Almalki, Afsana Sheikh, Salem Salman Almujri and Amirhossein Sahebkar and has published in prestigious journals such as Molecular Cancer, RSC Advances and Environmental Research.

In The Last Decade

Arif Nadaf

13 papers receiving 388 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Recent update on electrospinning and electrospun nanofibers: current trends and their applications

2022 169 citations Arif Nadaf, Akash Kumar Gupta et al. RSC Advances profile →
Skin cancer: understanding the journey of transformation from conventional to advanced treatment approaches

2023 123 citations Nazeer Hasan, Arif Nadaf et al. Molecular Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Arif Nadaf India	8	165	146	71	42	41	13	394
Zhiyong Qian China	16	115 0.7×	199 1.4×	137 1.9×	21 0.5×	91 2.2×	36	519
Joana Lopes Portugal	6	182 1.1×	177 1.2×	143 2.0×	21 0.5×	39 1.0×	11	447
Devasier Bennet South Korea	15	85 0.5×	184 1.3×	134 1.9×	29 0.7×	17 0.4×	22	510
Maria V. Lomova Russia	13	214 1.3×	219 1.5×	64 0.9×	51 1.2×	140 3.4×	33	607
Yijun Xiong China	7	174 1.1×	169 1.2×	139 2.0×	21 0.5×	78 1.9×	9	541
Huiqing Zhang China	9	69 0.4×	134 0.9×	77 1.1×	96 2.3×	117 2.9×	12	391
Vanshikha Singh India	11	162 1.0×	122 0.8×	165 2.3×	70 1.7×	52 1.3×	13	506
Ukrit Angkawinitwong United Kingdom	9	190 1.2×	120 0.8×	136 1.9×	25 0.6×	17 0.4×	10	464
Reza Faridi‐Majidi Iran	9	164 1.0×	142 1.0×	208 2.9×	16 0.4×	60 1.5×	15	626
Sofia M. Saraiva Portugal	10	86 0.5×	97 0.7×	65 0.9×	32 0.8×	46 1.1×	14	326

Countries citing papers authored by Arif Nadaf

Since Specialization

Citations

This map shows the geographic impact of Arif Nadaf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arif Nadaf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arif Nadaf more than expected).

Fields of papers citing papers by Arif Nadaf

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arif Nadaf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arif Nadaf. The network helps show where Arif Nadaf may publish in the future.

Co-authorship network of co-authors of Arif Nadaf

This figure shows the co-authorship network connecting the top 25 collaborators of Arif Nadaf. A scholar is included among the top collaborators of Arif Nadaf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arif Nadaf. Arif Nadaf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

1.

Nadaf, Arif, et al.. (2025). Cell membrane-engineered nanoparticles: A bionic platform for targeted cancer therapy. Biomaterials Advances. 178. 214471–214471. 3 indexed citations

2.

Nadaf, Arif, et al.. (2024). New opportunities for antioxidants in amelioration of neurodegenerative diseases. Mechanisms of Ageing and Development. 221. 111961–111961. 12 indexed citations

3.

Jain, Abhishek, et al.. (2024). Biomembrane camouflaged nanoparticles: A paradigm shifts in targeted drug delivery system. Colloids and Surfaces B Biointerfaces. 238. 113893–113893. 11 indexed citations

4.

Nadaf, Arif, Nazeer Hasan, Mohammad Adil, et al.. (2024). Gamma scintigraphy in sensing drug delivery systems. Nuclear Engineering and Technology. 56(10). 4423–4436. 1 indexed citations

5.

Barkat, Md. Abul, Nazeer Hasan, Mohd. Zaheen Hassan, et al.. (2024). Formulation development of methotrexate lipid-based nanogel for treatment of skin cancer. Colloids and Surfaces A Physicochemical and Engineering Aspects. 688. 133571–133571. 5 indexed citations

6.

Nadaf, Arif, et al.. (2024). Unlocking the potential of ibrutinib: A comprehensive review on its role in the multifaceted landscape of cancer therapy. Process Biochemistry. 143. 44–59. 1 indexed citations

7.

Nadaf, Arif, Nazeer Hasan, Akash Kumar Gupta, et al.. (2024). Leucocyte membrane camouflaged poly-lactic-co-glycolic acid (PLGA) nanoparticles containing cannabidiol and paclitaxel against breast cancer therapy. Process Biochemistry. 142. 88–103. 6 indexed citations

8.

Hasan, Nazeer, Mohammad Imran, Saurav Kumar Jha, et al.. (2023). Advanced targeted drug delivery by bioengineered white blood cell-membrane camouflaged nanoparticulate delivery nanostructures. Environmental Research. 238. 117007–117007. 20 indexed citations

9.

Nadaf, Arif, et al.. (2023). Carbon nanodots as a remedial nanovesicles for drug delivery. European Polymer Journal. 200. 112515–112515. 10 indexed citations

10.

Gupta, Akash Kumar, Arif Nadaf, Nazeer Hasan, et al.. (2023). Dasatinib: a potential tyrosine kinase inhibitor to fight against multiple cancer malignancies. Medical Oncology. 40(6). 173–173. 15 indexed citations

11.

Hasan, Nazeer, Arif Nadaf, Mohammad Imran, et al.. (2023). Skin cancer: understanding the journey of transformation from conventional to advanced treatment approaches. Molecular Cancer. 22(1). 168–168. 123 indexed citations breakdown →

12.

Nadaf, Arif, et al.. (2022). Recent update on electrospinning and electrospun nanofibers: current trends and their applications. RSC Advances. 12(37). 23808–23828. 169 indexed citations breakdown →

13.

Hasan, Nazeer, et al.. (2022). Review on 3D printing in dentistry: conventional to personalized dental care. Journal of Biomaterials Science Polymer Edition. 33(17). 2292–2323. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact